LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Treatment of CD19‐positive mixed phenotype acute leukemia with blinatumomab

Photo by nate_dumlao from unsplash

sion rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Pediatr Blood Cancer. 2012;58:61-65. 4. Brodsky MA, Rodeghier M, Sanger M, et… Click to show full abstract

sion rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Pediatr Blood Cancer. 2012;58:61-65. 4. Brodsky MA, Rodeghier M, Sanger M, et al. Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease. Am J Med. 2017;130:E9-15. 5. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005;79:17-25. 6. Han J, Saraf SL, Kavoliunaite L, et al. Program expansion of a day hospital dedicated to manage sickle cell pain. Am J Hematol. 2018;93:E20-E21.

Keywords: mixed phenotype; cd19 positive; positive mixed; treatment cd19; cell; sickle cell

Journal Title: American Journal of Hematology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.